Nabriva Therapeutics plc logo

Nabriva Therapeutics plc Employee Directory

Biotechnology ResearchDublin, Ireland11-50 Employees

Nabriva Therapeutics plc is a commercial-stage biotechnology company focused on developing novel antibiotics to treat serious infections. It is headquartered in Dublin, Ireland, with offices and laboratories in Vienna, Austria and King of Prussia, Pennsylvania, and additional locations in San Diego, California, United States. The company markets Xenleta (lefamulin), approved by the FDA for oral and intravenous use, and CONTEPO (fosfomycin) for injection, for which a US NDA has been submitted for complicated urinary tract infections including acute pyelonephritis. Recent strategic actions include the sale of Contepo assets to Meitheal Pharmaceuticals in July 2024 and prior asset divestitures such as Xenleta assets transferred to Sumitomo Pharma in 2023, with an earlier Merck collaboration in 2020 to market SIVEXTRO. The organization employs between 11 and 50 people.

Find Nabriva Therapeutics plc employees' phone numbers or email addresses

Nabriva Therapeutics plc Global Highlights

Location
Employees

North America
29

Minus sign iconPlus sign icon
  • United States Of America
    29

Europe
15

Minus sign iconPlus sign icon
  • Ireland
    11
  • Austria
    2
  • Germany
    1
  • Croatia
    1

Nabriva Therapeutics plc's Leadership

  • Chief Executive Officer, Nabriva Therapeutics at Nabriva Therapeutics plc
    J. J.
    Chief Executive Officer, Nabriva Therapeutics
  • Chief Medical Officer at Nabriva Therapeutics plc
    D. M.
    Chief Medical Officer
  • Clinical Trial Manager at Nabriva Therapeutics plc
    S. K.
    Clinical Trial Manager
  • Manager, Territory Business at Nabriva Therapeutics plc
    J. Z.
    Manager, Territory Business
  • Manager, Territory Business at Nabriva Therapeutics plc
    P. M.
    Manager, Territory Business
  • Assistant Manager at Nabriva Therapeutics plc
    S. A.
    Assistant Manager
  • Territory Sales Manager at Nabriva Therapeutics plc
    S. A.
    Territory Sales Manager
  • Senior Research Officer at Nabriva Therapeutics plc
    P. M.
    Senior Research Officer

Nabriva Therapeutics plc Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Sales
  • Accounting
  • Finance
  • Human Resources
  • Other
  • Research
  • Pharmaceuticals
  • Administrative
  • Community & Social Services
  • Biotechnology
  • Entrepreneurship

Contact profiles from Nabriva Therapeutics plc

Name
Title
Contact
Location
Last Update
  • Chief Medical Officer at Nabriva Therapeutics plc
    D. M.
    Chief Medical Officer
    Oct 23, 2024
  • Chief Executive Officer, Nabriva Therapeutics at Nabriva Therapeutics plc
    J. J.
    Chief Executive Officer, Nabriva Therapeutics
    Oct 23, 2024
  • Clinical Trial Manager at Nabriva Therapeutics plc
    S. K.
    Clinical Trial Manager
    Aug 01, 2026
  • Manager, Territory Business at Nabriva Therapeutics plc
    J. Z.
    Manager, Territory Business
    Oct 18, 2024
  • Manager, Territory Business at Nabriva Therapeutics plc
    P. M.
    Manager, Territory Business
    Oct 16, 2024
  • Assistant Manager at Nabriva Therapeutics plc
    S. A.
    Assistant Manager
    Oct 18, 2024
  • Territory Sales Manager at Nabriva Therapeutics plc
    S. A.
    Territory Sales Manager
    Oct 23, 2024
  • Senior Research Officer at Nabriva Therapeutics plc
    P. M.
    Senior Research Officer
    Austria, Vienna
    Jun 04, 2026

Frequently Asked Questions

What is Nabriva Therapeutics plc known for?

Minus sign iconPlus sign icon
Nabriva Therapeutics plc was founded in 2006 and operates in the Biotechnology Research industry. You can contact Nabriva Therapeutics plc's main corporate office by phone at . Explore Nabriva Therapeutics plc's company overview page for more information.

What is Nabriva Therapeutics plc's most common email format?

Minus sign iconPlus sign icon
Nabriva Therapeutics plc employees' email format typically follows the pattern of First.Last@nabriva.com. Trying to find reliable and up-to-date employee contact data? Find more Nabriva Therapeutics plc email formats with LeadIQ.

How many employees does Nabriva Therapeutics plc have currently?

Minus sign iconPlus sign icon
Nabriva Therapeutics plc has approximately 23 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Nabriva Therapeutics plc's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Nabriva Therapeutics plc's key employees include:

  • Chief Executive Officer, Nabriva Therapeutics: J. J.
  • Chief Medical Officer: D. M.
  • Clinical Trial Manager: S. K.
  • Manager, Territory Business: J. Z.
  • Manager, Territory Business: P. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.